• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma.

作者信息

Patel Krupesh, Allen Jeffrey, Zagzag David, Wisoff Jeffrey, Radmanesh Alireza, Gindin Tatyana, Nicolaides Theodore

机构信息

Department of Pediatrics, NYU Langone Health, New York, New York.

Department of Pathology, NYU Langone Health, New York, New York.

出版信息

Pediatr Blood Cancer. 2021 Mar;68(3):e28753. doi: 10.1002/pbc.28753. Epub 2020 Oct 19.

DOI:10.1002/pbc.28753
PMID:33073916
Abstract
摘要

相似文献

1
Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma.一名WNT激活型颅咽管瘤患者对MEK抑制的放射学反应。
Pediatr Blood Cancer. 2021 Mar;68(3):e28753. doi: 10.1002/pbc.28753. Epub 2020 Oct 19.
2
Melanotic craniopharyngioma, an unusual variant in a young female.
Neurol India. 2010 Jan-Feb;58(1):160-2. doi: 10.4103/0028-3886.60433.
3
Is there a role for targeted medical therapies in patients with craniopharyngiomas?
Future Oncol. 2015;11(24):3221-3. doi: 10.2217/fon.15.233. Epub 2015 Nov 12.
4
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.靶向治疗携带 BRAF V600E 突变的颅咽管瘤。
Cancer. 2019 Sep 1;125(17):2910-2914. doi: 10.1002/cncr.32197. Epub 2019 Jul 17.
5
Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour?恶性颅咽管瘤对基于顺铂的化疗有显著反应。颅咽管瘤应被视为鞍上“生殖细胞”肿瘤吗？
Br J Neurosurg. 2004 Oct;18(5):500-5. doi: 10.1080/02688690400012400.
6
Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report.博来霉素在囊性颅咽管瘤瘤内化疗中的应用。病例报告。
J Neurosurg. 1996 Jan;84(1):124-6. doi: 10.3171/jns.1996.84.1.0124.
7
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor.乳头型颅咽管瘤对BRAF抑制剂维莫非尼治疗有明显反应。
Pituitary. 2016 Oct;19(5):544-6. doi: 10.1007/s11102-015-0663-4.
8
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.BRAF V600E突变型乳头状颅咽管瘤对靶向治疗的显著反应
J Natl Cancer Inst. 2015 Oct 23;108(2). doi: 10.1093/jnci/djv310. Print 2016 Feb.
9
BRAF plus MEK inhibition effective in papillary craniopharyngioma.BRAF加MEK抑制对乳头状颅咽管瘤有效。
Nat Rev Clin Oncol. 2023 Oct;20(10):661. doi: 10.1038/s41571-023-00807-5.
10
[Studies on craniopharyngioma in tissue culture (author's transl)].
Neurol Med Chir (Tokyo). 1980 Mar;20(3):247-55. doi: 10.2176/nmc.20.247.

引用本文的文献

1
Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches.颅咽管瘤病理生理学的最新进展及新兴治疗方法
Front Endocrinol (Lausanne). 2025 May 13;16:1562942. doi: 10.3389/fendo.2025.1562942. eCollection 2025.
2
Targeted treatment for craniopharyngioma.颅咽管瘤的靶向治疗
J Neurooncol. 2025 May;172(3):503-513. doi: 10.1007/s11060-025-04942-0. Epub 2025 Feb 14.
3
Molecular subtypes of adamantinomatous craniopharyngiomas.成釉细胞瘤型颅咽管瘤的分子亚型
Neuro Oncol. 2025 Feb 3. doi: 10.1093/neuonc/noaf030.
4
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression.复发性造釉细胞瘤型颅咽管瘤存在 MAPK 通路激活、克隆进化以及罕见的 TP53 缺失介导的恶性进展。
Acta Neuropathol Commun. 2024 Aug 10;12(1):127. doi: 10.1186/s40478-024-01838-4.
5
Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma.将系统治疗整合到颅咽管瘤患者的多模态治疗中。
Curr Treat Options Oncol. 2024 Feb;25(2):261-273. doi: 10.1007/s11864-023-01156-2. Epub 2024 Feb 1.
6
Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.推进颅咽管瘤管理：当前靶向治疗的系统评价及未来展望。
Int J Mol Sci. 2024 Jan 5;25(2):723. doi: 10.3390/ijms25020723.
7
Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review.成釉细胞瘤型颅咽管瘤的治疗进展：在当前环境下如何平衡肿瘤控制与生活质量：一项叙述性综述
Front Oncol. 2023 Dec 21;13:1326595. doi: 10.3389/fonc.2023.1326595. eCollection 2023.
8
Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes.小儿间脑肿瘤的新型治疗方法：改善功能预后
Front Oncol. 2023 Oct 10;13:1178553. doi: 10.3389/fonc.2023.1178553. eCollection 2023.
9
Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance.多组学分析颅咽管瘤揭示了具有预后和治疗反应意义的不同分子亚群。
Chin Med J (Engl). 2024 Apr 5;137(7):859-870. doi: 10.1097/CM9.0000000000002774. Epub 2023 Aug 11.
10
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.BRAF介导的成人和儿童脑肿瘤：综述及澳大利亚和新西兰的经验
Front Oncol. 2023 Apr 14;13:1154246. doi: 10.3389/fonc.2023.1154246. eCollection 2023.